Headline
BREAKING: Bad News For Those Who Received COVID-19 Vaccines

Bad News For Those Who Received COVID-19 Vaccines.
This could prove fatal for many people who took the vaccine in the past weeks or months in South Africa.
OnyxNews Nigeria gathered that the president of South Africa, Cyril Ramaphosa bought a batch of COVID-19 vaccines in the past months and it was great news that many citizens were going to fight the ravaging pandemic virus called coronavirus (COVID-19).
The government bought a batch of COVID-19 vaccines from Johnson & Johnson and many frontline workers were among the first to get vaccinated by Johnson & Johnson, according to @AdvoBarryRoux/twitter.
Meanwhile, according to the CNN, the US has ordered the halt of the distribution of the J&J vaccines over blood clot concerns.
READ How Bill Gates Sets To Block The Sun From Reaching The Earth
This could prove fatal to the patient who took the vaccines.
There has been no news from the government of South Africa about this issue.
-
Headline6 days ago
FG and World Bank at Loggerheads Over N54.9tn 2025 Budget Revenue Assumptions
-
Headline6 days ago
JUST IN: House of Representatives Rejects Bill On Zoning Presidency, Alongside Six Other Constitutional Amendments
-
Headline1 week ago
Barcelona’s Stunning Comeback Secures 4-3 El Clasico Victory Over Real Madrid, Moves Closer to La Liga Glory
-
Crime6 days ago
Nigerian Police and INTERPOL Arrest Canadian and Nigerian Fraudsters in $210,000 and N452 Million Scams
-
Entertainment1 week ago
AMVCA 2025: Full List Of Winners
-
Headline5 days ago
Lamido Links June 12 Annulment to Military’s Refusal to Pay N45bn Debt to Abiola, Calls on Tinubu for Resolution
-
Headline1 week ago
India and Pakistan Agree to Full Ceasefire Following U.S.-Mediated Talks, Trump Announces
-
Entertainment6 days ago
US Rapper, Diddy Sets To Face Life In Prison Over Allege Sex Trafficking
-
Entertainment1 week ago
Seven Doors Leads the Pack at AMVCA 2025 with Top Acting Awards
-
Brands and Marketing4 days ago
UPDATED: Naira Falls To N1,635/$ In Parallel Market